Loxapine Capsule
Product Images NDC 70518-0346

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Loxapine (NDC 70518-0346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy Label

Loxapine 5 mg capsules packaging label showing a quantity of 30 capsules. The label includes the NDC number 70518-0346-00, manufacturer Actavis in Sunrise, FL, and repackager RemedyRepack Inc. Directions advise storing at 20-25°C with permitted excursions. The label also includes safety information to keep medications out of reach of children.*

FDA Label Image

The Structurla Formula Of Loxapine, A Dibenzoxazepine Compound, Represents A Subclass Of Tricyclic Antipsychotic Agents, Chemically Distinct From The Thioxanthenes, Butyrophenones, And Phenothiazines. (Image 1)

Chemical structure of Loxapine base, showing its molecular framework and atom connectivity. The diagram is labeled with the name 'LOXAPINE BASE' below the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.